Respiratory tract infection clinical trials
10 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
- An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
- Functional Impact of Acute Respiratory Viral Infections in Older Adults
- Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
- Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
- Preparedness Through Respiratory Virus Epidemiology and Community Engagement
- Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
- Viral Infections in Healthy and Immunocompromised Hosts
- Analysis of the Virtual Acute Care at Home Experience
- Beetroot Juice NO Cold Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Respiratory tract infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.